Use of recombinant human antithrombin concentrate in pregnancy.
Publication
, Journal Article
Kreuziger, LMB; Prosen, TL; Reding, MT
Published in: Int J Womens Health
2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Int J Womens Health
DOI
ISSN
1179-1411
Publication Date
2013
Volume
5
Start / End Page
583 / 586
Location
New Zealand
Related Subject Headings
- 4204 Midwifery
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kreuziger, L. M. B., Prosen, T. L., & Reding, M. T. (2013). Use of recombinant human antithrombin concentrate in pregnancy. Int J Womens Health, 5, 583–586. https://doi.org/10.2147/IJWH.S52208
Kreuziger, Lisa M Baumann, Tracy L. Prosen, and Mark T. Reding. “Use of recombinant human antithrombin concentrate in pregnancy.” Int J Womens Health 5 (2013): 583–86. https://doi.org/10.2147/IJWH.S52208.
Kreuziger LMB, Prosen TL, Reding MT. Use of recombinant human antithrombin concentrate in pregnancy. Int J Womens Health. 2013;5:583–6.
Kreuziger, Lisa M. Baumann, et al. “Use of recombinant human antithrombin concentrate in pregnancy.” Int J Womens Health, vol. 5, 2013, pp. 583–86. Pubmed, doi:10.2147/IJWH.S52208.
Kreuziger LMB, Prosen TL, Reding MT. Use of recombinant human antithrombin concentrate in pregnancy. Int J Womens Health. 2013;5:583–586.
Published In
Int J Womens Health
DOI
ISSN
1179-1411
Publication Date
2013
Volume
5
Start / End Page
583 / 586
Location
New Zealand
Related Subject Headings
- 4204 Midwifery
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis